Global AI In Predictive Toxicology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2025 to 2033

Description

List of Tables

Global AI In Predictive Toxicology Market is poised to witness substantial growth, reaching a value of USD 5.37 Billion by the year 2033, up from USD 0.5 Billion attained in 2024. The market is anticipated to display a Compound Annual Growth Rate (CAGR) of 30.04% between 2025 and 2033.

The AI in predictive toxicology market is undergoing rapid transformation as machine learning algorithms and big data analytics enhance the accuracy and speed of toxicity assessments. By leveraging vast chemical and biological datasets, AI models are enabling early identification of toxicological risks, reducing reliance on animal testing and expediting drug development pipelines. The integration of deep learning techniques with in silico modeling is facilitating the prediction of complex toxicological endpoints, including genotoxicity and immunotoxicity, with unprecedented precision. This technological advancement is critical for regulatory compliance and safety evaluation across pharmaceuticals, chemicals, and consumer products.

Furthermore, the convergence of AI with high-throughput screening and omics technologies is generating multidimensional datasets that refine predictive models and support mechanistic understanding of toxicity pathways. Cloud-based platforms and collaborative data-sharing initiatives are democratizing access to AI tools, fostering innovation and standardization in toxicology assessments. As regulatory agencies increasingly endorse AI-driven methodologies, the market is poised for accelerated adoption, driving safer product development and reducing time-to-market for novel compounds.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

LIST OF SEGMENTS COVERED

This section of the AI In Predictive Toxicology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Component

Solution
Services

By Technology

Machine Learning
Natural Language Processing
Computer Vision
Others

By Toxicity Endpoints

Genotoxicity
Hepatotoxicity
Neurotoxicity
Cardiotoxicity
Others

By End User

Pharmaceutical & Biotechnology Companies
Chemical & Cosmetics
Contract Research Organizations
Others
List of Companies Profiled in the report
Benevolent AI, Berg Health, Biovista, Celsius Therapeutics, Chemaxon Ltd., Cyclica, Exscientia PLC, Insilico Medicine, Instem plc, Lhasa Limited, Recursion Pharmaceuticals.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR112116775

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. AI IN PREDICTIVE TOXICOLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Component
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Toxicity Endpoints
- 3.7.4 Market Attractiveness Analysis By End User
- 3.7.5 Market Attractiveness Analysis By Regions

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY COMPONENT

5.1. Overview By Component
5.2. Historical and Forecast Data Analysis By Component
5.3. Solution Historic and Forecast Sales By Regions
5.4. Services Historic and Forecast Sales By Regions

6. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data Analysis By Technology
6.3. Machine Learning Historic and Forecast Sales By Regions
6.4. Natural Language Processing Historic and Forecast Sales By Regions
6.5. Computer Vision Historic and Forecast Sales By Regions
6.6. Others Historic and Forecast Sales By Regions

7. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY TOXICITY ENDPOINTS

7.1. Overview By Toxicity Endpoints
7.2. Historical and Forecast Data Analysis By Toxicity Endpoints
7.3. Genotoxicity Historic and Forecast Sales By Regions
7.4. Hepatotoxicity Historic and Forecast Sales By Regions
7.5. Neurotoxicity Historic and Forecast Sales By Regions
7.6. Cardiotoxicity Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY END USER

8.1. Overview By End User
8.2. Historical and Forecast Data Analysis By End User
8.3. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions
8.4. Chemical & Cosmetics Historic and Forecast Sales By Regions
8.5. Contract Research Organizations Historic and Forecast Sales By Regions
8.6. Others Historic and Forecast Sales By Regions

9. GLOBAL AI IN PREDICTIVE TOXICOLOGY MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE AI IN PREDICTIVE TOXICOLOGY COMPANIES

10.1. AI In Predictive Toxicology Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF AI IN PREDICTIVE TOXICOLOGY INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Benevolent AI
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Berg Health
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Biovista
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. Celsius Therapeutics
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Chemaxon Ltd.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Cyclica
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Exscientia PLC
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Insilico Medicine
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Instem Plc
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Lhasa Limited
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments
11.13. Recursion Pharmaceuticals
- 11.13.1 Company Overview
- 11.13.2 Company Revenue
- 11.13.3 Products
- 11.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of privcompanies